C12N 2750/14152
Relating to complementing cells and packaging systems for producing virus or viral
Official title: relating to complementing cells and packaging systems for producing virus or viral particles
C12N2750/14152 (Relating to complementing cells and packaging systems for producing virus or viral) appears on 228 US grants and 557 published applications in this corpus.
Search patents in C12N- Granted patents
- 228
- Published applications
- 557
- Assignees
- 228
- Inventors
- 1,009
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 3 | 1 |
| 2002 | 6 | 13 |
| 2003 | 7 | 7 |
| 2004 | 2 | 10 |
| 2005 | 5 | 5 |
| 2006 | 5 | 5 |
| 2007 | 4 | 4 |
| 2008 | 2 | 4 |
| 2009 | 2 | 8 |
| 2010 | 4 | 3 |
| 2011 | 0 | 4 |
| 2012 | 1 | 1 |
| 2013 | 3 | 6 |
| 2014 | 4 | 10 |
| 2015 | 9 | 10 |
| 2016 | 7 | 18 |
| 2017 | 8 | 15 |
| 2018 | 11 | 14 |
| 2019 | 12 | 21 |
| 2020 | 16 | 31 |
| 2021 | 13 | 39 |
| 2022 | 15 | 47 |
| 2023 | 19 | 60 |
| 2024 | 21 | 65 |
| 2025 | 21 | 80 |
| 2026 | 21 | 76 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- ABCD1 for treatment of neurodisorders15 Sep 2026US 12,735,706 B2The General Hospital Corporation
- AAV production strategy using a cell line expressing an inducible rep gene1 Sep 2026US 12,723,249 B2University of Massachusetts
- Isolated modified AAV9 capsid protein VP125 Aug 2026US 12,714,756 B2
- Modified AAV capsids and uses thereof16 Jun 2026US 12,653,909 B2Solid Biosciences Inc.
- Cell lines for production of adeno-associated virus9 Jun 2026US 12,649,908 B2The University of North Carolina at Chapel Hill
- Compositions and methods for recombinant aav production8 Oct 2026US 2026/0308620 A1REGENXBIO Inc.
- Single plasmid system for aav production8 Oct 2026US 2026/0308623 A1Solid Biosciences Inc.
- Nannochloropsis-producing viruses and methods and compositions for making the same1 Oct 2026US 2026/0297502 A1Insmed Incorporated
- Cell lines and methods for producing recombinant adeno-associated virus1 Oct 2026US 2026/0297616 A1Regents of the University of Minnesota
- Viral and non-viral nanoplasmid vectors with improved production24 Sep 2026US 2026/0286384 A1Aldevron, LLC
Most cited
By later US patents
- Hybrid adenovirus-AAV virus and methods of use thereof311US 5,871,982 AThe Trustees of the University of Pennsylvania · 1999
- Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor288US 7,282,199 B2The Trustees of the University of Pennsylvania · 2007
- Adeno-associated virus (AAV) serotype 8 sequences, vectors containing the same, and uses therefor220US 7,790,449 B2The Trustees of the University of Pennsylvania · 2010
- Methods for generating high titer helper-free preparations of released recombinant AAV vectors183US 6,566,118 B1Targeted Genetics Corporation · 2003
- Method for detecting adeno-associated virus165US 8,524,446 B2The Trustees of the University of Pennsylvania · 2013